IL10 and colorectal carcinoma: Inflammation is further associated with CRC risk in our study as indicated by the interaction between circulating 25(OH)D concentrations, which has anti-inflammatory properties [52,53], and genetic variation in the IL10 gene encoding anti-inflammatory cytokine interleukin (IL)-10 involved in immune response to pathogens [54].